Join
Live feed
·
PRReleasevia Quantisnow
DSS Inc. logo
ProPhase Labs Inc. logo

DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase Labs

ByQuantisnow·Wall Street's wire, on your screen.
Consumer DiscretionaryHealth Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DSS (DSS Inc.), PRPH (ProPhase Labs Inc.) and more on Quantisnow.